Novartis Wins EU Approval for Lucentis for Myopic Choroidal Neovascularization
Novartis International AG has informed that Lucentis has got European Commission approval for treatment of patients suffering from choroidal neovascularization. Swiss pharmaceutical giant has registered sales of $2.4 billion during year 2012 for Lucentis, launched by the company in 2006.
Lucentis has already been approved in European Union for age-related macular degeneration and visual impairment due to macular edema secondary to vien occlusion in retina. Novartis informed that single injection of Lucentis has proved helpful in 70% of the patients and they achieved good results in rapid visual gains.
Novartis performed study under name RADIANCE for patients suffering from myopic choroidal neovascularization. The study subjects were feeling better effects of the treatment with 2 injections in 60% of the cases. The patients didn't require any additional injections after six months.
Novartis competes with Regeneron's Eylea in the same segment. Eylea has been gaining market share in Europe and United States, market dominated by Lucentis since its launch in 2006 in United States. In United States, the drug is sold by Genentech, the US subsidiary of Swiss pharmaceutical giant Roche AG.
New Zealand News
- Porsche reportedly developing electric version of 718 sports car
- Tesla Model Y Performance becomes little bit more expensive to order in China
- Porsche’s recently unveiled Mission R Concept previews electric race cars of future
- Chinese manufacturer GAC’s Aion V e-SUV can charge 0-80% in just 8 minutes
- Oshidori International exits Japanese casino race, citing serious ethical irregularities
- Plug-in cars’ share grows to 32% in Netherlands in September 2021
- Italian motorcycle racer Valentino Rossi enters e-bike business with VR46 MTB range
- Micro Mobility shows off production version of Microlino 2.0 and 3-wheeled e-scooter
- Chinese electric motorcycle maker Evoke Motorcycles to set up shops in Spain
- TenneT adds more electric BMWs to study use of EVs to support power grids